Literature DB >> 26123135

The pathophysiology of hypertensive acute heart failure.

David M Viau1, Javier A Sala-Mercado2, Marty D Spranger2, Donal S O'Leary2, Phillip D Levy3.   

Abstract

While acute heart failure (AHF) is often regarded as a single disorder, an evolving understanding recognises the existence of multiple phenotypes with varied pathophysiological alterations. Herein we discuss hypertensive AHF and provide insight into a mechanism where acute fluid redistribution is caused by a disturbance in the ventricular-vascular coupling relationship. In this relationship, acute alterations in vascular elasticity, vasoconstriction and reflected pulse waves lead to increases in cardiac work and contribute to decompensated LV function with associated subendocardial ischaemia and end-organ damage. Chronic predisposing factors (neurohormonal activity, nitric oxide insensitivity, arterial stiffening) and physiological stressors (sympathetic surge, volume overload, physical exertion) that are causally linked to acute symptom onset are discussed. Lastly, we review treatment options including both nitrovasodilators and promising novel therapeutics, and discuss future directions in the management of this phenotypic variant. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Year:  2015        PMID: 26123135     DOI: 10.1136/heartjnl-2015-307461

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  17 in total

Review 1.  Focused Update on Pharmacologic Management of Hypertensive Emergencies.

Authors:  Kristin Watson; Rachael Broscious; Sandeep Devabhakthuni; Zachary R Noel
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

2.  Serial Sonographic Assessment of Pulmonary Edema in Patients With Hypertensive Acute Heart Failure.

Authors:  Jennifer L Martindale; Michael Secko; John F Kilpatrick; Ian S deSouza; Lorenzo Paladino; Andrew Aherne; Ninfa Mehta; Alyssa Conigiliaro; Richard Sinert
Journal:  J Ultrasound Med       Date:  2017-07-31       Impact factor: 2.153

Review 3.  Therapies to Reduce Blood Pressure Acutely.

Authors:  Joseph B Miller; Harish Kinni; Ahmed Amer; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

Review 4.  Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment.

Authors:  Eva M Boorsma; Jozine M Ter Maaten; Kevin Damman; Wilfried Dinh; Finn Gustafsson; Steven Goldsmith; Daniel Burkhoff; Faiez Zannad; James E Udelson; Adriaan A Voors
Journal:  Nat Rev Cardiol       Date:  2020-05-15       Impact factor: 32.419

Review 5.  Blood Pressure Reduction in Hypertensive Acute Heart Failure.

Authors:  Nicholas Harrison; Peter Pang; Sean Collins; Phillip Levy
Journal:  Curr Hypertens Rep       Date:  2021-02-20       Impact factor: 5.369

Review 6.  Optimising Heart Failure Therapies in the Acute Setting.

Authors:  Mattia Arrigo; Petra Nijst; Alain Rudiger
Journal:  Card Fail Rev       Date:  2018-05

Review 7.  Optimizing Hypertensive Acute Heart Failure Management with Afterload Reduction.

Authors:  Sean Collins; Jennifer Martindale
Journal:  Curr Hypertens Rep       Date:  2018-02-24       Impact factor: 5.369

8.  Efficacy of urapidil for the treatment of patients with senile hypertension and acute heart failure.

Authors:  Yan-Zhong Xie; Jian-Ming Ni; Shan-Jing Zhang; Guo-Rong Ding; Jun-Fei Feng
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

9.  Pressure-dependent NOS activation contributes to endothelial hyperpermeability in a model of acute heart failure.

Authors:  Andreia Z Chignalia; Ayman Isbatan; Milan Patel; Richard Ripper; Jordan Sharlin; Joelle Shosfy; Barry A Borlaug; Randal O Dull
Journal:  Biosci Rep       Date:  2018-11-23       Impact factor: 3.840

10.  Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis.

Authors:  Jiaxiao Shi; Yulin Li; Cong Xing; Peng Peng; Hongyu Shi; Han Ding; Pengyuan Zheng; Guangzhi Ning; Shiqing Feng
Journal:  Drug Des Devel Ther       Date:  2018-12-27       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.